Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/0775 stock hub

HKG/0775 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0775is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.2B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0775

In the news

Latest news · HKG/0775

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-5.1

P25 -14.7P50 2P75 9.4

ROIC-1.3

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0775 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

HKD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	1,920
Employees Change	-113%
Employees Change Percent	-5.56
Enterprise value	HKD 13.3B
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG2176J1058
Last refreshed	2026-05-10
Market cap	HKD 7.2B
Price	HKD 0.75
Price currency	HKD
Rev Per Employee	2,817,827.08x
Sector	Healthcare
Sic	2836
Symbol	hkg/0775
Website	https://www.ck-lifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.59%
EV Earnings	-71.16x
EV/EBITDA	115.95x
EV/FCF	-229.05x
EV/Sales	2.46x
FCF yield	-0.81%
P/B ratio	1.87x
P/S ratio	1.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.42%
EBITDA Margin	0.58%
Gross margin	29.15%
Gross Profit	HKD 1.6B
Gross Profit Growth	-6.51%
Gross Profit Growth Q	-12.3%
Gross Profit Growth3 Y	-1.24%
Gross Profit Growth5 Y	-0.83%
Net Income	HKD -186.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-0.33%
Profit Margin	-3.45%
Profit Per Employee	HKD -97,295
ROA	-0.72
Roa5y	0.7
ROCE	-1.57
ROE	-5.12
Roe5y	-0.28
ROIC	-1.33
Roic5y	0.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.67%
Cagr15y	3.96%
Cagr1y	-11.77%
Cagr20y	0.84%
Cagr3y	-1.8%
Cagr5y	-0.02%
Div CAGR10	2.92%
Div CAGR3	-7.17%
Div CAGR5	-4.36%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	-47.12%
OCF Growth Q	-7.27%
OCF Growth10 Y	-9.91%
OCF Growth3 Y	-31.4%
OCF Growth5 Y	-4.07%
Revenue Growth	-2.04x
Revenue Growth Q	-2.86x
Revenue Growth Years	0x
Revenue Growth3 Y	0.19x
Revenue Growth5 Y	0.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.48
Assets	HKD 11.8B
Cash	HKD 603.1M
Current Assets	HKD 3B
Current Liabilities	HKD 3.5B
Debt	HKD 6.6B
Debt EBITDA	HKD 57.93
Debt Equity	HKD 1.72
Debt FCF	HKD -114
Equity	HKD 3.8B
Interest Coverage	-0.49
Liabilities	HKD 8B
Long Term Assets	HKD 8.8B
Long Term Liabilities	HKD 4.5B
Net Cash	HKD -6B
Net Cash By Market Cap	HKD -83.49
Net Debt EBITDA	HKD 191
Net Debt Equity	HKD 1.56
Tangible Book Value	HKD 829M
Tangible Book Value Per Share	HKD 0.09
WACC	4.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	3.21
Net Working Capital	HKD 1.4B
Quick ratio	0.46
Working Capital	HKD -461.2M
Working Capital Turnover	HKD 56.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	HKD 0
Last Dividend	HKD 0.01

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	6.89%
1Y total return	-11.76%
200-day SMA	0.86
3Y total return	-5.3%
50-day SMA	0.75
50-day SMA vs 200-day SMA	50under200
5Y total return	-0.08%
All Time High	1.96
All Time High Change	-61.73%
All Time High Date	2003-09-09
All Time Low	0.18
All Time Low Change	316.67%
All Time Low Date	2008-10-23
ATR	0.02
Beta	0.4
Beta1y	1.08
Beta2y	1.17
Ch YTD	-8.54
High	0.75
High52	1.08
High52 Date	2025-10-09
High52ch	-30.56%
Low	0.72
Low52	0.64
Low52 Date	2026-03-30
Low52ch	17.19%
Ma50ch	0.05%
Price vs 200-day SMA	-12.65%
RSI	55.24
RSI Monthly	51.68
RSI Weekly	42.47
Sharpe ratio	-0.74x
Sortino ratio	-0.85
Tr YTD	-8.54
Tr15y	79.1%
Tr1m	2.74%
Tr1w	2.74%
Tr3m	-8.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -131M
Operating margin	-2.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,404,637,115%
Net Borrowing	456,457,000
Shares Insiders	22.2%
Shares Institutions	0.7%
Shares Out	9,611,072,400
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -58M
Average Volume	1,937,529x
Bv Per Share	0.39
CAPEX	HKD -245M
Ch10y	-5.06
Ch15y	51.52
Ch1m	2.74
Ch1w	2.74
Ch1y	-11.76
Ch3m	-8.54
Ch3y	-6.25
Ch5y	-3.85
Ch6m	-12.79
Change	0%
Change From Open	4.17
Close	0.75
Days Gap	-4
Depreciation Amortization	162,525,000
Dollar Volume	2,275,500
Earnings Date	2026-05-12
EBIT	HKD -131M
EBITDA	HKD 31.5M
EPS	HKD -0.02
F Score	3
FCF	HKD -58M
FCF EV Yield	-0.44x
FCF Per Share	HKD -0.01
Financing CF	192,675,000
Fiscal Year End	December
Founded	1,999
Goodwill	2,790,355,000
Income Tax	HKD 170.4M
Investing CF	-346,501,000
Is Primary Listing	1
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Ma150	0.83
Ma150ch	-9.7%
Ma20	0.73
Ma20ch	2.18%
Net CF	49,097,000
Next Earnings Date	2026-05-12
Open	0.72
P OCF Ratio	38.56
Position In Range	100
Ppne	4,265,165,000
Price Date	2026-05-08
Price EBITDA	HKD 229
Ptbv Ratio	8.7
Relative Volume	1.6x
Revenue	5,410,228,000x
Tax By Revenue	3.15x
Tr20y	18.21%
Tr6m	-12.79%
Volume	3,034,000
Z Score	1.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/0775 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/0775 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0775?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+22.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/0775 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

-12.6%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0775

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0775 stock rating?

hkg/0775 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0775 analysis?

The full report lives at /stocks/hkg/0775/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0775?

The latest report frames hkg/0775 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0775 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.